Arena Pharmaceuticals Inc
ARNA
ARNA was delisted on the 10th of March, 2022.
235 hedge funds and large institutions have $3.35B invested in Arena Pharmaceuticals Inc in 2021 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 96 increasing their positions, 63 reducing their positions, and 31 closing their positions.
80% more call options, than puts
Call options by funds: $57.6M | Put options by funds: $32M
52% more repeat investments, than reductions
Existing positions increased: 96 | Existing positions reduced: 63
0% more first-time investments, than exits
New positions opened: 31 | Existing positions closed: 31
1% less funds holding
Funds holding: 237 → 235 (-2)
13% less capital invested
Capital invested by funds: $3.87B → $3.35B (-$518M)
17% less funds holding in top 10
Funds holding in top 10: 6 → 5 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
United Kingdom
|
+$68.6M |
| 2 |
LGM
Logos Global Management
San Francisco,
California
|
+$30.1M |
| 3 |
SCM
Suvretta Capital Management
New York
|
+$30M |
| 4 |
Goldman Sachs
New York
|
+$29.1M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$20.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Holocene Advisors
New York
|
-$83.5M |
| 2 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$49.3M |
| 3 |
ACA
Avoro Capital Advisors
New York
|
-$38.4M |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$23.7M |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$23.6M |
ARNA Hedge Fund Activity: Q3 2021 in Review
235 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Arena Pharmaceuticals Inc (ARNA) for Q3 2021, worth a combined $3.35B — down 13% from $3.87B a quarter earlier.
Fund positioning in ARNA was balanced in Q3 2021: 31 funds opened new positions, 31 closed out, 96 added to existing stakes and 63 trimmed.
The largest buyer was Janus Henderson Group, adding an estimated $68.6M. The largest seller was Holocene Advisors, exiting entirely with an estimated $83.5M sold.
- 235 institutional investors held Arena Pharmaceuticals Inc (ARNA) as of Q3 2021, down from 237 in Q2 2021.
- Funds reported $3.35B of Arena Pharmaceuticals Inc stock for Q3 2021, down 13% quarter-over-quarter.
- 31 funds opened new Arena Pharmaceuticals Inc positions in Q3 2021 and 31 closed out, a net change of 0 holders.
- The largest Arena Pharmaceuticals Inc buyer in Q3 2021 was Janus Henderson Group, an estimated $68.6M added.
- The largest Arena Pharmaceuticals Inc seller in Q3 2021 was Holocene Advisors, an estimated $83.5M sold.
Based on aggregated 13F filings for Q3 2021.